title: Special considerations in early-stage breast cancer patients and survivors.
abstract: Long-term outcomes for early-stage breast cancer have continued to improve, and more patients are becoming long-term survivors. In addition to patients' concern about risk of developing recurrent disease, they are also concerned about potential toxicities of treatment. Current guidelines for long-term follow-up are reviewed. Potential toxicities of tamoxifen and aromatase inhibitors are reviewed. Management of menopausal symptoms, cancer-related fatigue, and cognitive function is discussed.
authors.affiliation: Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, 1365 Clifton Road Northeast, Atlanta, GA 30322, USA. Electronic address: amelia.zelnak@emory.edu.
authors.forename: Amelia B
authors.initials: AB
authors.lastname: Zelnak
mesh_terms: D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology*; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D017410:Practice Guidelines as Topic; D015996:Survival Rate
keywords: Breast cancer; Genomic profiling; Subtypes; Survivorship